Note sull'episodio
In this episode of WHV Insider, Steve Moore is joined by Bruce Gaffney, CEO of KaRama Venture Studio, for a Meet the Investor conversation on what it actually takes to build, not just import, medtech and biotech ventures inside Saudi Arabia.
Bruce isn't a typical investor. Starting his first business at 17, an encrypted communications platform and an early internet banking system, he was once told, "What is internet? And do you think people will manage finances with a computer and not a human?"
Despite dismissals, he recognised that when something seems too difficult or like a dream, it's time to act. This mindset led him from New York through the GCC and UAE to Riyadh. Today, KaRama Venture Studio operates in the SFDA campus, building a portfolio of 15 companies in two years, focusing on local IP, capability, and manufacturing over importing international products. Bruce offers blunt insights into what works and what doesn't in Saudi.
Bruce notes that raising capital now requires understanding that investors are shifting from quick real estate returns to biotech’s 10-15 year horizons. He's clear that no one invests because you're cool or Western.
In this episode, we also cover:
- Bruce's route from a first startup at 17 to venture building in Riyadh, and the bank meeting that shaped his whole approach
- How KaRama Venture Studio has built 15 companies in two years from inside the SFDA campus
- Why investor culture in the Kingdom is shifting from real estate return horizons to biotech ones, and why raising is materially easier than it was two years ago
- Vision 2030 at the ten-year mark: the taxi driver test, and the shift from marketing value to hard financial and job creation metrics
- Why being physically on the SFDA campus is "a live-in relationship, not a long-distance one", and what that actually buys you
- When IP registration and regulatory work should start, and why day-one filings are often wasted money
- The MVP discipline most founders lack: knowing when to stop developing and start selling
- The single pitch line that switches Bruce off immediately
- Where academia is essential to a health venture, and where market validation matters more
- How the recent regional conflict accelerated the case for local manufacturing and supply chain resilience
- The leapfrog thesis: why Saudi Arabia will deploy the most advanced medical technology first
- Whether you really need a local Saudi partner — and what genuinely being based in the Kingdom looks like
- Why so many Vision 2030 slides are written by people who have never read Vision 2030
For anyone weighing a move into the Saudi health technology market, this is a practical, unsentimental account of how ventures actually get built in the Kingdom — and why, as Bruce puts it, you should build the relationships first and let the business follow.
Find Bruce Gaffney and KaRama Venture Studio at karamavs.com or on LinkedIn.